Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0244 Transporter Info | ||||
| Gene Name | SLC28A1 | ||||
| Protein Name | Concentrative nucleoside transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs2242046 | ||||
| Site of GPD | chr15:84935498 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A / G>T | ||||
| Minor Allele Frequency | A=0.2081/1042 (Global) | ||||
| Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Gemcitabine | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the decreased hematologic toxicity risk in patients (compare with genotypes AA + AG) | [ 1] | |
| Genetic Polymorphism | rs2290271 | ||||
| Site of GPD | chr15:84904404 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>C | ||||
| Minor Allele Frequency | C=0.4383/2195 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
| Daunorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A) | [ 2] | |
| Doxorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele A) | [ 2] | |
| Anthracyclines | N.A. | Neoplasm | Correlated with the decreased likelihood of cardiotoxicity in patients (compare with Allele A) | [ 3] | |
| Genetic Polymorphism | rs2305364 | ||||
| Site of GPD | chr15:84909044 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
| Daunorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C) | [ 2] | |
| Doxorubicin | Drug Info | Neoplasm | Irrelevant to the likelihood of cardiotoxicity in patients (compare with allele C) | [ 2] | |
| Anthracyclines | N.A. | Neoplasm | Correlated with the increased likelihood of cardiotoxicity in patients (compare with allele C) | [ 3] | |
| References | |||||
| 1 | Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. Lung Cancer. 2009 Jan;63(1):121-7. | ||||
| 2 | Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81. | ||||
| 3 | Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.